To the full analysis
Community Health Systems stock: growth
CYHCommunity Health Systems reported $12.49B in revenue for fiscal 2025, down 1.2% on the prior year, up 1.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
5.7%
per year from 2006 to 2025, per share 3.8%
Earnings (Annual rate)
6%
per year from 2006 to 2025, per share 4.1%
Free cash flow (Annual rate)
2.7%
per year from 2006 to 2025, per share 0.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 1.2% | −4.3% | 5.7% |
| Revenue per share | −1.7% | −5.8% | 3.8% |
| Earnings | −0.1% | 12.4% | 6.0% |
| Earnings per share | −2.9% | 10.7% | 4.1% |
| Free cash flow | −34.6% | no data | 2.7% |
| Free cash flow per share | −36.5% | no data | 0.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.37B | $168.26M | $125.74M |
| 2007 | $7.13B | $30.29M | $164.95M |
| 2008 | $10.84B | $218.3M | $365.05M |
| 2009 | $12.11B | $243.15M | $499.54M |
| 2010 | $11.4B | $279.98M | $521.35M |
| 2011 | $11.91B | $201.95M | $69.84M |
| 2012 | $13.03B | $265.64M | $511.33M |
| 2013 | $13B | $141.2M | $474.73M |
| 2014 | $18.64B | $92M | $762M |
| 2015 | $19.44B | $158M | −$89M |
| 2016 | $18.44B | −$1.72B | $1.49B |
| 2017 | $15.35B | −$2.46B | $203M |
| 2018 | $14.16B | −$788M | −$253M |
| 2019 | $13.21B | −$590M | −$53M |
| 2020 | $11.79B | $511M | $1.74B |
| 2021 | $12.37B | $230M | −$600M |
| 2022 | $12.21B | $46M | −$115M |
| 2023 | $12.49B | −$133M | −$257M |
| 2024 | $12.63B | −$516M | $120M |
| 2025 | $12.49B | $509M | $208M |
Revenue by segment
How Community Health Systems, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Managed Care And Other Third Party Payors48%
- Medicare17%
- Medicaid16%
- Other19%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Managed Care And Other Third Party Payors | $5.98B | $6.08B | $5.98B | 47.9% |
| Medicare | $2.48B | $2.28B | $2.17B | 17.4% |
| Medicaid | $1.79B | $1.87B | $1.99B | 15.9% |
| Other | $2.24B | $2.4B | $2.35B | 18.8% |
| Total revenue | $12.49B | $12.63B | $12.49B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 20 Feb 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.